Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents

[PR Newswire] – MARLBOROUGH, Mass., Aug. 29, 2014 /PRNewswire/ — A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture resolution of benign … Read more . . . → Read More: Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents Similar Articles: Stock Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs Medtronic Inc (NYSE:MDT) | Medtronic settles heart valve patent fight with Edwards Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes